Skip to main content

Is taro.com a Scam? Security Check Results - Taro Pharmaceutical Industries Ltd.

taro.com Security Report Summary

taro.com received a security score of 66 out of 100 in Guard's comprehensive security analysis, classified as "Moderate Risk". This report covers Taro Pharmaceutical Industries Ltd.'s website security posture. Taro Pharmaceutical Industries Ltd. operates in the Healthcare industry in United States.

Taro Pharmaceutical Industries Ltd. is a well-established pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. The company is now a wholly owned subsidiary of Sun Pharma, a global healthcare leader. The website reflects a corporate presence with sections dedicated to products, research, investor relations, and affiliated sites. The target audience includes healthcare professionals, investors, and consumers seeking pharmaceutical products. The business model focuses on pharmaceutical manufacturing, research, and distribution with a strong market position supported by its parent company Sun Pharma. Technically, the website is built on Drupal 7 with legacy jQuery libraries and uses several JavaScript plugins for UI components. The site is moderately optimized for mobile devices and has a good design and navigation structure. However, some technical debt is evident due to outdated libraries and lack of modern security headers. Hosting appears to be managed with AT&T DNS services, and no advanced analytics or tracking services were detected. From a security perspective, the site uses HTTPS (implied by the domain and typical corporate practice), but lacks DNSSEC and security headers. The WHOIS data shows a long-established domain with appropriate domain locks, indicating legitimacy. No explicit security or incident response policies are published, and no vulnerability disclosure or security.txt files were found. The site lacks a cookie consent mechanism, which may impact privacy compliance. Overall, the website is professional and trustworthy but could improve its security posture and privacy compliance. Strategic recommendations include upgrading outdated libraries, enabling DNSSEC, implementing security headers, and adding cookie consent mechanisms to enhance user trust and regulatory compliance.

The security scan identified 28 findings across security headers, SSL/TLS, DNS health, email security, GDPR compliance, and NIS2 compliance analysis modules.

Technologies detected: jQuery 1.7.2, Drupal 7, jQuery DC Mega Menu, jQuery mmenu, jQuery zAccordion, easyResponsiveTabs.

About this security scan

Guard performs automated security assessments of websites by analyzing SSL/TLS certificates, HTTP security headers, DNS configuration, email authentication protocols (SPF, DKIM, DMARC), GDPR compliance indicators, NIS2 directive compliance, network exposure, and AI-powered business intelligence. Each report provides domain-specific findings, risk scores, and actionable recommendations.

taro.com favicon

Is taro.com Safe? Security Analysis for Taro Pharmaceutical Industries Ltd.

https://taro.com

Check if taro.com is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Stateslarge
jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordion+1 more
Analyzed 9/7/2025Completed 5:46:23 AM9mo ago
66
Security Score
MEDIUM RISK

Above Healthcare avg (65)

10,000+

Domains scanned

500+

Security teams trust us

EveryPay

Secure checkout

Instant

Reports delivered

Professional PDF & Marketing Data

Get the professional PDF report for taro.com

Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domaintaro.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

AI Summary

Taro Pharmaceutical Industries Ltd. is a well-established pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. The company is now a wholly owned subsidiary of Sun Pharma, a global healthcare leader. The website reflects a corporate presence with sections dedicated to products, research, investor relations, and affiliated sites. The target audience includes healthcare professionals, investors, and consumers seeking pharmaceutical products. The business model focuses on pharmaceutical manufacturing, research, and distribution with a strong market position supported by its parent company Sun Pharma. Technically, the website is built on Drupal 7 with legacy jQuery libraries and uses several JavaScript plugins for UI components. The site is moderately optimized for mobile devices and has a good design and navigation structure. However, some technical debt is evident due to outdated libraries and lack of modern security headers. Hosting appears to be managed with AT&T DNS services, and no advanced analytics or tracking services were detected. From a security perspective, the site uses HTTPS (implied by the domain and typical corporate practice), but lacks DNSSEC and security headers. The WHOIS data shows a long-established domain with appropriate domain locks, indicating legitimacy. No explicit security or incident response policies are published, and no vulnerability disclosure or security.txt files were found. The site lacks a cookie consent mechanism, which may impact privacy compliance. Overall, the website is professional and trustworthy but could improve its security posture and privacy compliance. Strategic recommendations include upgrading outdated libraries, enabling DNSSEC, implementing security headers, and adding cookie consent mechanisms to enhance user trust and regulatory compliance.

Detected Technologies

jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordioneasyResponsiveTabs

9 urgent findings need attention

9 high

  • + 1 more findings in the full report below
Continuous monitoring

Keep taro.com under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay
Less than 1 € / day — cheaper than a single incident response hour

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Purchase to access the monitoring timeline, JSON diffs, alert history, and PDF export for taro.com.

Security Headers

5 findings

60/100

GDPR Compliance

4 findings

53/100

NIS2 Compliance

9 findings

2/100

Email Security

2 findings

87/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Business Intelligence

Market & Strategic Analysis

Taro Pharmaceutical Industries operates in the healthcare sector with a focus on pharmaceutical manufacturing and research. Its ownership by Sun Pharma positions it strongly in the global pharmaceutical market. The company maintains multiple subsidiaries targeting different geographic markets including the USA, Canada, Israel, and international markets. The website supports investor relations and corporate communications, indicating a transparent and mature business model. The partnership ecosystem includes Sun Pharma and affiliated companies like Chattem Chemicals. The company targets healthcare professionals, investors, and consumers, leveraging its research capabilities and product portfolio to maintain competitive advantage. Growth indicators include recent merger announcements and active investor communications.

Security Posture Analysis

Comprehensive Security Assessment

The current security posture is moderate but with notable gaps. The domain is secured with transfer and update prohibitions, indicating good domain management. However, the absence of DNSSEC and security headers reduces protection against DNS spoofing and common web attacks. The use of outdated jQuery 1.7.2 introduces potential vulnerabilities. No public security or incident response policies are available, and no dedicated security contact channels were found. Privacy compliance is partial, lacking cookie consent mechanisms. Overall, the site is functional and legitimate but requires improvements to meet modern security and privacy standards.

Strategic Recommendations

Priority Actions for Security Improvement

1

Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.

Observations

AI-powered comprehensive website and business analysis.

AI-Enhanced Website Analysis

Business Insights

Company:

Taro Pharmaceutical Industries Ltd.

Description:

Taro Pharmaceutical Industries is a pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. It is now a privately held company wholly owned by Sun Pharma, a global healthcare company with innovative therapies, generic medicines, and consumer healthcare products.

Key Services:
Pharmaceutical product manufacturingResearch and developmentInvestor relations
Content Quality:

good

Branding:

consistent

Technical Stack

Technologies:
jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordioneasyResponsiveTabs
Frameworks:
Drupal 7
Performance:

moderate

Mobile:

good

Accessibility:

basic

SEO:

basic

Security Assessment

Security Score:
55/100
Best Practices:
  • Domain status includes clientTransferProhibited and serverUpdate/Delete/TransferProhibited flags

Analytics & Tracking

Tracking Level:minimal
Privacy Compliance:basic

Advertising & Marketing

Transparency Level:poor

Website Quality Assessment

Design Quality:good
User Experience:good
Content Relevance:good
Navigation Clarity:good
Professionalism:good
Trustworthiness:high

Key Observations

1

Website is a corporate pharmaceutical site with clear business focus.

Get this report delivered to your inbox

Receive a summary of the taro.com security findings by email. Quick and easy to share with decision makers.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Security Headers

HTTP security headers analysis

60/100
Score

Weak X-Content-Type-Options configuration

LOW

Current value: "nosniff, nosniff"

Missing Content-Security-Policy header

HIGH

Controls resources the browser is allowed to load

Missing X-XSS-Protection header

MEDIUM

Legacy XSS protection (deprecated but still recommended)

Missing Referrer-Policy header

LOW

Controls referrer information sent with requests

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

GDPR Compliance

Privacy and data protection assessment

53/100
Score

No Cookie Policy found

HIGH

GDPR requires clear information about cookie usage

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy0% confidence
Contact Information Found90% confidence
phone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

NIS2 Compliance

Network & Information Security Directive

2/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity

No security contact information

HIGH

NIS2 requires clear incident reporting channels

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts

Critical sector without clear security compliance

HIGH

Detected sectors: transport, banking, health, digital

Need this report as a PDF?

Download the complete taro.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Email Security

SPF, DKIM, and DMARC validation

87/100
Score

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 ip4:67.132.78.84 ip4:202.87.61.70 include:spf.protection.outlook.com include:spf-test.gps.ihost.com include:spf-prod.gps.ihost.com -all
DNS Lookups:3/10
Policy:-all
DKIM Selectors Found
Selector:selector1(1416-bit rsa)
DMARC Details
Policy:reject
Aggregate Reports:rua.sunpharma@progist.in
Forensic Reports:notes.admin@sunpharma.com

🏆SSL/TLS Security

Certificate validity and encryption analysis.

SSL/TLS Security

Certificate validity and encryption analysis

67/100
Score

Weak Protocols Supported

HIGH

Server supports weak protocols: TLSv1.1

OCSP Stapling Not Enabled

LOW

OCSP stapling improves performance and privacy

Certificate Transparency Not Implemented

LOW

Certificate is not logged in Certificate Transparency logs

Mixed Content Detected

MEDIUM

14 resources loaded over insecure HTTP

Partial SSL/TLS Assessment

LOW

Completed 3 of 4 security checks due to time constraints

Protocol Support

TLSv1.3TLSv1.2TLSv1.1

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

DNS Health

DNS configuration and security assessment

85/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found

DNS Records

A Records:159.60.142.184
Name Servers:
dbru.br.ns.els-gms.att.netDNS only
dmtu.mt.ns.els-gms.att.netDNS only
MX Records:
0: taro-com.mail.protection.outlook.com
SOA:Serial: 115, TTL: 86400s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:184ms

SPF Analysis

SPF Record:
v=spf1 ip4:67.132.78.84 ip4:202.87.61.70 include:spf.protection.outlook.com include:spf-test.gps.ihost.com include:spf-prod.gps.ihost.com -all

Network Security

Port scanning and network exposure analysis.

Network Security

Port scanning and network exposure analysis

100/100
Score

Good Network Security Posture

LOW

No unnecessary services detected on common risky ports

How does taro.com compare?

See how taro.com stacks up against similar websites in the same industry.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

The website is built on Drupal 7 CMS, which is an older platform but still widely used. The front-end relies on jQuery 1.7.2 and several jQuery plugins for UI elements like mega menus, responsive tabs, and accordions. The site uses CSS imports and JavaScript files hosted on the same domain, indicating self-hosted assets. The site is mobile responsive with a dedicated mobile menu. Performance is moderate, with no explicit performance optimization scripts detected. SEO is basic with meta tags and RSS feed links present. Accessibility features are minimal but include skip links and basic ARIA roles. The hosting provider is not explicitly stated but DNS nameservers suggest AT&T infrastructure. The site lacks modern security headers and DNSSEC, which are technical risks. Overall, the infrastructure is functional but could benefit from modernization and security enhancements.
Professional PDF & Marketing Data

Download the taro.com report as PDF

Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domaintaro.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

Scan your own website

Liked the taro.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.

Or browse our directory of >10,000 scanned websites.

⭐ Verified Community Reviews

What others say about taro.com

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website